Skip to main content
Equibles

Logos Global Management LP

Position in DSGN — Design Therapeutics, Inc.

CIK 1792126 San Francisco, CA
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$43,410,000
+$22,662,000 QoQ
Shares Held
3,000,000
+53.8% QoQ
Ownership
4.79%
of shares outstanding
% of Portfolio
1.87%
of 13F equity value
Holder Rank
#2
of 136 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Logos Global Management LP holds $2,282,084,584 across 63 Biotechnology names. DSGN ranks #17 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ERAS
Erasca, Inc.
 12,150,000 $222,588,000
2 ABVX
Abivax S.A.
 1,024,000 $136,458,240
3 RVMD
Revolution Medicines, Inc.
 700,000 $131,096,000
4 IDYA
IDEAYA Biosciences, Inc.
 3,000,000 $111,810,000
5 BNTX
BioNTech SE
 1,015,000 $94,445,750
6 VERA
Vera Therapeutics, Inc.
 2,200,000 $94,402,000
7 TNGX
Tango Therapeutics, Inc.
 2,850,000 $89,091,000
8 PRAX
Praxis Precision Medicines, Inc.
 260,000 $87,045,400

All Filings in DSGN

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $43,410,000 3,000,000
2026-03-31 $20,748,000 1,950,000
2025-12-31 $23,450,000 2,500,000
2025-09-30 $27,522,150 3,655,000
2025-06-30 $14,213,402 4,217,627
2025-03-31 $16,280,040 4,217,627
2024-12-31 $26,022,758 4,217,627
2024-09-30 $22,690,833 4,217,627
2024-06-30 $16,858,878 5,032,501
2024-03-31 $20,280,979 5,032,501
2023-12-31 $13,336,127 5,032,501
2023-09-30 $11,876,702 5,032,501
2023-06-30 $17,624,256 2,797,501
2023-03-31 $16,141,580 2,797,501
2022-12-31 $28,702,360 2,797,501
2022-09-30 $46,774,216 2,797,501
2022-06-30 $39,165,014 2,797,501
2022-03-31 $45,179,641 2,797,501
2021-12-31 $59,359,246 2,772,501
2021-09-30 $40,728,039 2,772,501
2021-06-30 $54,349,444 2,732,501
2021-03-31 $81,701,779 2,732,501